Assessment of the Efficacy of FOSFOMYCIN in Patients With Bacterial Infection
NCT ID: NCT01173575
Last Updated: 2019-07-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
209 participants
OBSERVATIONAL
2010-08-31
2016-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Primary objective:
• To assess clinical and microbiological efficacy of FOM in patients with bacterial infection.
Secondary objectives:
* To determine the rate and severity of unexpected adverse events.
* To determine the mean duration of therapy with FOM in patients with bacterial infection.
Study design:
Multi-center, non-interventional study
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Fosfomycin I.v. for Treatment of Severely Infected Patients
NCT02979951
Use of Fosfomycin in the Treatment of Bacterial Infections
NCT06814899
Clinical Impact of Fluoroquinolone Resistance in Bacteremia Caused by Gram-Negative Bacilli of Urinary Tract Origin
NCT00414362
Fosfomycin Versus Meropenem or Ceftriaxone in Bacteriemic Infections Caused by Multidrug Resistance in E.Coli
NCT02142751
Intravenous Fosfomycin Pharmacokinetics Study
NCT03910673
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Bacterial Infection
All Patients with bacterial infection receiving fosfomycin may be included
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
J&P Medical Research Ltd.
OTHER
Sandoz GmbH
INDUSTRY
Infectopharm Arzneimittel GmbH
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Medical University Graz
Graz, Styria, Austria
University Hospital Tübingen
Tübingen, Baden-Wurttemberg, Germany
Augsburg Hospital
Augsburg, Bavaria, Germany
Kreisklinik Guenzburg Krumbach
Krumbach, Bavaria, Germany
University Hospital Munich
Munich, Bavaria, Germany
University Hospital Regensburg
Regensburg, Bavaria, Germany
Weiden Hospital
Weiden in Der Oberpfalz, Bavaria, Germany
University Hospital Frankfurt
Frankfurt am Main, Hesse, Germany
Evangelische Krankenhausstiftung Oldenburg
Oldenburg, Lower Saxony, Germany
Klinikum Oldenburg gGmbH
Oldenburg, Lower Saxony, Germany
Klinikum Osnabrück
Osnabrück, Lower Saxony, Germany
University Hospital Greifswald
Greifswald, Mecklenburg-Vorpommern, Germany
Heart and Diabetes Center North Rhine-Westphalia
Bad Oeynhausen, North Rhine-Westphalia, Germany
Medizinische Universitätsklinik Knappschaftskrankenhaus Bochum
Bochum, North Rhine-Westphalia, Germany
University of Bonn (Orthopedics)
Bonn, North Rhine-Westphalia, Germany
University of Bonn (Anesthesiology)
Bonn, North Rhine-Westphalia, Germany
University Hospital Cologne (Cardiothoracic Surgery)
Cologne, North Rhine-Westphalia, Germany
University Hospital Cologne (Internal Medicine)
Cologne, North Rhine-Westphalia, Germany
Hospital Cologne-Merheim
Cologne, North Rhine-Westphalia, Germany
University Hospital Düsseldorf
Düsseldorf, North Rhine-Westphalia, Germany
University Hospital Muenster
Münster, North Rhine-Westphalia, Germany
University Hospital Schleswig-Holstein, Campus Kiel
Kiel, Schleswig-Holstein, Germany
Vivantes Klinikum Neukölln
Berlin, , Germany
Charite University Hospital Berlin
Berlin, , Germany
Paulinenhaus Krankenanstalt e.V.
Berlin, , Germany
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Putensen C, Ellger B, Sakka SG, Weyland A, Schmidt K, Zoller M, Weiler N, Kindgen-Milles D, Jaschinski U, Weile J, Lindau S, Kieninger M, Faltlhauser A, Jung N, Teschendorf P, Adamzik M, Grundling M, Wahlers T, Gerlach H, Litty FA. Current clinical use of intravenous fosfomycin in ICU patients in two European countries. Infection. 2019 Oct;47(5):827-836. doi: 10.1007/s15010-019-01323-4. Epub 2019 Jun 12.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
J&P009SAN/2009
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.